Monocyte-mediated T cell suppression by HIV-2 envelope proteins

Area of Science:

• Immunology
• Virology

Background:

• Human Immunodeficiency Virus type 2 (HIV-2) infection typically results in a milder disease course compared to HIV type 1.
• Immunosuppression is a key consequence of HIV infection, yet T cell depletion necessitates T cell activation.
• The role of HIV-2 specific proteins in its attenuated disease progression remains incompletely understood.

Purpose of the Study:

• To investigate the immunosuppressive effects of the HIV-2 envelope protein, gp105.
• To elucidate the mechanism by which gp105 mediates T cell suppression.
• To explore the potential contribution of these immunosuppressive properties to the attenuated pathogenesis of HIV-2.

Main Methods:

• In vitro assays to assess T cell activation in the presence of HIV-2 gp105.
• Monocyte-mediated suppression assays.
• Analysis of Toll-like receptor 4 (TLR4) pathway activation and Tumor Necrosis Factor-alpha (TNF-alpha) production by monocytes.

Main Results:

• The HIV-2 envelope protein gp105 suppresses T cell activation.
• This suppression is mediated by monocytes and requires direct contact between monocytes and T cells.
• gp105 activates the TLR4 pathway in monocytes, leading to TNF-alpha production, suggesting a role for this pathway in immunosuppression.

Conclusions:

• HIV-2 gp105 suppresses T cell activation through a monocyte-dependent mechanism involving TLR4 signaling.
• These findings support a novel concept where HIV-2 envelope proteins modulate monocyte function to inhibit T cell activation.
• This immunosuppressive property may contribute to the less severe disease progression observed in HIV-2 infection by limiting T cell activation bursts and reducing viral load.